Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing‐remitting multiple sclerosis

DOI: 10.1111/jnc.13881

,

Issn Print: 0022-3042

Publication Date: 2017/04/01

Lenka Novakova; Markus Axelsson; Mohsen Khademi; Henrik Zetterberg; Kaj Blennow; Clas Malmeström; Fredrik Piehl; Tomas Olsson; Jan Lycke

Author Information: Department of Clinical Neuroscience, Institute of Neuroscience and Physiology at Sahlgrenska Academy


		Checking for direct PDF access through Ovid

View on Journal Site

Abstract unavailable for this article.


		Loading Related Articles